Business Context and Reporting Period
This Form 6-K filing by Prima BioMed Ltd (not Immutep Ltd as noted in metadata) is dated July 24, 2015. The company is a foreign private issuer headquartered in Sydney, Australia, and files annual reports on Form 20-F.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial event disclosed is a capital raise of A$10 million through a Share Purchase Plan.
Material Changes
The material change reported is the successful execution of a Share Purchase Plan raising A$10 million. No comparative financial data or prior period metrics are included in this specific filing text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, future guidance, risk factors, or details on contingencies beyond the announcement of the capital raise.
Investor Verification Checklist
- Verify the final closing details and share issuance count for the A$10 million Share Purchase Plan.
- Confirm the intended use of proceeds from the capital raise.
- Review the company's latest Form 20-F for comprehensive financial statements and liquidity position.
- Check for any subsequent filings regarding the impact of this capital raise on the company's cash runway.